| Literature DB >> 21836823 |
Abstract
With the burgeoning array of molecular tests available in the epilepsies, the clinician needs to know which tests to order for each patient. Epileptic encephalopathies are the most important clinical group for genetic testing with an increasing number of distinctive epilepsy syndromes being recognized. Identification of the causative mutation affects treatment as well as prognostic and genetic counseling.Entities:
Year: 2011 PMID: 21836823 PMCID: PMC3152152 DOI: 10.5698/1535-7511-11.4.107
Source DB: PubMed Journal: Epilepsy Curr ISSN: 1535-7511 Impact factor: 7.500